This study revealed the function of PLAGL1 in reducing PAAD progression and its previously unrecognized prognostic value, providing new insight into the tumor biology of PAAD and providing us with a novel prognostic marker and therapeutic strategy that warrant investigation. This evidence concerns the gene PLAGL1 and pancreatic adenocarcinoma.